PA
ProstaLund develops and manufactures CoreTherm, a patented thermotherapy method for treating benign prostatic hyperplasia (BPH) that can be customized for individual patient needs. This technology provides a minimally invasive solution to alleviate urinary symptoms associated with BPH, currently utilized in hospitals and clinics globally.
Updated 3 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- ProstaLund develops and manufactures CoreTherm, a patented thermotherapy method for treating benign prostatic hyperplasia (BPH) that can be customized for individual patient needs. This technology provides a minimally invasive solution to alleviate urinary symptoms associated with BPH, currently utilized in hospitals and clinics globally.